Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 9/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 3/20 | 0.38 |
| ▸ | PIK3CB | P42338 | 3/20 | 0.38 |
| ▸ | BRD4 | O60885 | 1/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.34 |
| ▸ | MTOR | P42345 | 1/20 | 0.34 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22944856 | 0.93 | PRKDC (0.35) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL22945997 | 0.91 | PRKDC (0.35) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL22945539 | 0.90 | PRKDC (0.35) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL22945553 | 0.89 | PRKDC (0.35) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL22945519 | 0.89 | ALOX5 (0.38) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL22945524 | 0.89 | ALOX5 (0.39) | PRKDCPIK3CDPIK3CBALOX5 | |
| SCHEMBL22945109 | 0.88 | PRKDC (0.42) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL22945455 | 0.87 | PRKDC (0.35) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL22945110 | 0.87 | ALOX5 (0.35) | PRKDCPIK3CDPIK3CBBRDTALOX5 | |
| SCHEMBL22945200 | 0.86 | ALOX5 (0.36) | PRKDCPIK3CDPIK3CBBRD4PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11812658-B2 | Compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-11812658-B2 | Compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-20210036236-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210036236-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | DRD1, DRD3, DRD2 | PRKDC 4810/4885PIK3CD 4301/4885PIK3CB 4706/4885 |
| US-11812658-B2 | Compound and organic light emitting diode comprising same | DRD1, DRD3, DRD2 | PRKDC 4810/4885PIK3CD 4301/4885PIK3CB 4706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.